University of Colorado Denver Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Location status: Recruiting
Location contact
Anna Euser, MD
SUB_INVESTIGATOR
Colleen Julian, PhD
SUB_INVESTIGATOR
Lorna Moore, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT02391519
Pregnancy elicits adaptive changes in uteroplacental blood flow, which are altered at high altitude and may contribute to the observed 3-fold increase in intrauterine growth restriction (IUGR) and preeclampsia (PreE). The investigators propose to collect myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA). If altered MA vasoreactivity is found, further studies may be able to link these changes to the increased rates of PreE and IUGR at altitude and contribute to the understanding of these two disorders.
Interested in participating?
Request Info18 year–45 year
Female
Observational
Aurora, Colorado, 80045, United States
Location status: Recruiting
Anna Euser, MD
SUB_INVESTIGATOR
Colleen Julian, PhD
SUB_INVESTIGATOR
Lorna Moore, PhD
PRINCIPAL_INVESTIGATOR
The Investigators will determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries. This will be novel information regarding pregnancy at altitude and of significance not just for women and families in Colorado, but also at high-altitude locations throughout the world. If altered MA vasoreactivity is found, further studies may be able to link these changes to the increased rates of PreE and IUGR at altitude and contribute to the understanding of these two disorders.
The Investigators will also determine whether the chronic hypoxia of high altitude alters DNA methylation patterns and expression of key genes involved in metabolic homeostasis in maternal, placental and fetal cells and, in turn, the relationship of these changes to fetal growth and maternal well-being.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We propose to collect myometrial, cord blood, and placental tissue samples from women at high altitude (Summit County) and low altitude (Denver) in Colorado in order to determine if residence at altitude during pregnancy changes the vasoreactivity of myometrial arteries (MA).
Time frame: Up to 1 year
Myometrial artery dimensions as quantified by immunohistochemistry or other staining techniques, and results of studies of isolated myometrial artery studies in which vasoconstrictor and vasodilator responses to pharmacological agonists are measured using absolute values and the percent maximal contraction to potassium chloride.
Contact information is provided by the study sponsor or research team.
University of Colorado, Denver
Other
Effects of High Altitude on 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) Activation and Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Regulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06861309
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death
Roanoke, Virginia, United States
View Trial DetailsNCT07565727
Cardiometabolic Diseases, Diabetes Mellitus
Knoxville, Tennessee, United States
View Trial DetailsNCT07229261
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Milwaukee, Wisconsin, United States
View Trial DetailsNCT06802861
Body Weight, Diabetes Mellitus
Knoxville, Tennessee, United States
View Trial Details